Comment: Immunotherapy combo increases median survival in advanced melanoma

Success for ipilimumab and nivolumab combo in advanced melanoma

T-VEC injections into melanoma lesions show significant response rate

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer

Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence

ASCO 2014 roundup

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers

Regorafenib shows early promise in colorectal candidates unable to undergo chemo

Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute lymphoblastic leukaemia

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer

Mantle cell lymphoma: A review of data and expert opinion from ASCO 2014